Dr. Ruina Macariola Wilson, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1830 Town Ctr Dr, #101, Reston, VA 20190 Phone: 703-437-8397 Fax: 703-709-0675 |
Dr. Robert James Banks, DMD General Practice Medicare: Not Enrolled in Medicare Practice Location: 11800 Sunrise Valley Dr., Suite 1137, Reston, VA 20191 Phone: 703-391-8836 Fax: 703-391-6802 |
Charles E Dyer, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1850 Town Center Pkwy, Emergency Department, Reston, VA 20190 Phone: 703-689-9039 |
News Archive
Women have a two-fold higher risk of developing Alzheimer's disease than men, yet strikingly little is known about how changes in brain function promote this difference - and how early in midlife those changes can be detected.
"According to the latest report from the Independent Monitoring Board of the Global Polio Eradication Initiative, continued transmission of polio is a 'global health emergency,' and plans to interrupt transmission by the end of 2012 are 'at risk,'" the Lancet Infectious Diseases reports, adding, "With a US$590 million funding gap and weak political leadership in some countries, the engagement of communities to plan and implement local approaches is paramount."
The U.S. 'race gap' in the commission of violent crime has narrowed substantially, yet persists in many cities - with murder arrest rates for African Americans out-distancing those for whites - concludes a new 80-city study by the University of Maryland, Florida State University and the University of Oregon.
The New York Times examines how "[a] set of proposed international sex education guidelines aimed at reducing H.I.V. infections among young people" and unplanned pregnancies, based on "more than 80 studies of sex education," has received some criticism. The release of the final guidelines, originally scheduled for next week by the United Nations Educational, Scientific and Cultural Organization (UNESCO), has been delayed.
Today the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee voted overwhelmingly (13 to 2) to recommend BENLYSTA® for approval as a treatment for the autoimmune disease lupus. If FDA approved, BENLYSTA would become the first new treatment for lupus in 52 years. While today's vote is a positive step, the FDA still must make a final decision to approve BENLYSTA in the coming weeks.
› Verified 8 days ago